v3.25.3
Unaudited Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Sep. 30, 2025
Sep. 30, 2024
Revenues        
Product revenue, net $ 115,361,000 $ 101,847,000 $ 330,095,000 $ 289,102,000
Collaboration revenue 734,000 418,000 2,464,000 816,000
Total revenues 116,095,000 102,265,000 332,559,000 289,918,000
Expenses        
Cost of product revenue (46,764,000) (36,569,000) (128,219,000) (105,336,000)
Cost of collaboration revenue (119,000) (348,000) (531,000) (433,000)
Research and development (47,928,000) (65,982,000) (159,271,000) (182,252,000)
Selling, general, and administrative (70,106,000) (67,219,000) (204,566,000) (216,123,000)
Loss from operations (48,822,000) (67,853,000) (160,028,000) (214,226,000)
Interest income 8,345,000 9,029,000 25,794,000 28,017,000
Interest expenses (1,400,000) (745,000) (3,848,000) (1,350,000)
Foreign currency gains 6,422,000 14,457,000 9,909,000 8,281,000
Other income (expense), net (508,000) 3,441,000 3,045,000 3,859,000
Loss before income tax (35,963,000) (41,671,000) (125,128,000) (175,419,000)
Income tax expense 0 0 0 0
Net loss $ (35,963,000) $ (41,671,000) $ (125,128,000) $ (175,419,000)
Loss per share - basic (in dollars per share) $ (0.03) $ (0.04) $ (0.11) $ (0.18)
Loss per share - diluted (in dollars per share) $ (0.03) $ (0.04) $ (0.11) $ (0.18)
Weighted-average shares used in calculating net loss per ordinary share - basic (in shares) 1,102,072,680 981,687,390 1,091,690,340 976,941,030
Weighted-average shares used in calculating net loss per ordinary share - diluted (in shares) 1,102,072,680 981,687,390 1,091,690,340 976,941,030